RxDoctor Payments Data

Michael Worley, NP

Family · Tucson, AZNPI 1548704125

Payments from drug & device makers

$481in general payments, 2019–2025

Across 27 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$144
  • GSK$56
  • Indivior Inc.$52
  • Novo Nordisk$36
  • Lilly USA, LLC$30
  • Otsuka America Pharmaceutical, Inc.$24
  • plus $139 from 9 others

What the payments were for

  • Food & beverage$481100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$481 in reported general payments places this provider in the 55th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$3,102
Medicare patients
22
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin29$16,355
Advair HfaFluticasone Propion/Salmeterol34$12,334
JanuviaSitagliptin Phosphate14$9,408
MyrbetriqMirabegron14$6,738
Atrovent HfaIpratropium Bromide13$6,362
SymbicortBudesonide/Formoterol Fumarate26$6,233
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl31$5,281
Albuterol Sulfate HfaAlbuterol Sulfate132$4,042
Atorvastatin Calcium173$1,722
Gabapentin98$1,634
Omeprazole100$1,533
Ranolazine ErRanolazine21$1,524
Famotidine60$1,055
Lisinopril125$928
Metformin Hcl78$858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$144$16,35529 claims
MerckJanuvia$13$9,40814 claims
AstraZenecaSymbicort$14$6,23326 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,119 family providers in Arizona.

Other family in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →